EAN News

Prior to the COVID-19 pandemic, EAN decided to launch a taskforce on Gender and Diversity in Neurology. The Task Force will become a Coordinating Panel by March 2022.

Would you like to play a part in hitting EAN’s educational goals and delivering exceptional resources and opportunities for our members? EAN would like to invite academically active European neurologists to apply to join the EAN Education Committee.

It is our pleasure to introduce the new EAN Scientific Panels’ Management groups for the 2022-2024 period.

EAN Programme Committee Chair, Tony Marson, on abstract submission, registration and the preliminary programme for EAN 2022.

The OneNeurology European Summit took place on 17 December 2021 under the patronage of the Slovenian Presidency in the Council of the EU

The European Academy of Neurology launched the first of its new National Neurological Society Forum meetings on Wednesday, December 15. Representatives from more than 40 societies which are EAN institutional members joined the meeting to get a glimpse of EAN’s progress in advocating for neurology and brain health on the European level.

The HBP and EBRAINS together with the European Academy of Neurology invited the entire scientific community to join a workshop on the Future of Medical Data Sharing in Clinical Neurosciences on 9–11 December 2021.

Did you miss any interesting EAN educational events last year? Check out all our webcasts from the virtual events!.

The editorial team of the European Journal of Neurology welcomes two new colleagues, starting in January 2022. Alessandro Tessitore and Barbara Borroni have both joined as Associate Editors.

Registration is now open for the OneNeurology European Summit, taking place virtually on Friday, 17 December.

EAN President, Claudio Bassetti gives some deep insights into the EAN's recent advocacy activity and plans for the future.

Our research paper of the month is an open-label, single-arm, phase II futility trial exploring the safety and the effect of treatment with the antimalarial drug hydroxychloroquine on disability worsening in patients with primary progressive multiple sclerosis.

In November 2021, the European Pain Federation and Pain Alliance Europe organised the annual SIP forum. For the second year in a row, we met virtually due to the COVID-19 pandemic.

7th Swiss Narcolepsy Day – 22 January, 2022

57th Turkish Neurology Congress – 27 November to 1 December